How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cancer Patient Protection Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE via SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
2013 · second_quarter · Q2
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Source: Senate LDA
Breast Cancer Patient Protection Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Cancer Drug Coverage Parity Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Breast Cancer Patient Education Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Breast Cancer Patient Education Act of 2013
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Drug Supply Chain Security Act
Client: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE · Firm: SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), SENATE
SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE via SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
2013 · first_quarter · Q1
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer screening and research. Pub. Law No. 113-6, Consoldiated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer screening and research.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE